Early Abduction Splintage on Stable Hips in Infants With Developmental Dysplasia of the Hip
NCT ID: NCT02885831
Last Updated: 2019-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2016-12-08
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment for Mild Hip Dysplasia in Newborns
NCT00843258
Ultrasound Screening for Developmental Dysplasia of the Hip in Newborns
NCT01818934
Psychomotor Therapy for Very Premature Infants
NCT03093337
Automatic Characterization of the Neonatal Hip Using Ultrasound Imaging
NCT02796768
Neonatal Neurobehavioral And Motor Behavior In Ultra Early Physical Therapy Intervention
NCT05565287
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A - Abduction splintage
Treatment by abduction splintage. Sonographic, clinical and radiographic surveillance. 45 patients.
Abduction splintage
Treatment by abduction splintage 24 hours a day and 7 days a week, for 2 months.
B - Surveillance
No treatment by abduction splintage. Sonographic, clinical and radiographic surveillance. 45 patients
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abduction splintage
Treatment by abduction splintage 24 hours a day and 7 days a week, for 2 months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants between 1 and 2 months of age at inclusion
* Clinically stable hip
* Pathological ultrasonography : pubo-femoral distance \>6mm and bony rim percentage \<50%
* Non objection of the family
Exclusion Criteria
* Normal ultrasonography
* Neuro-orthopedic disease
* Postural deformity of the pelvis
* Participation refusal
1 Month
2 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias THEPAUT, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Brest
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Matthias THEPAUT
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Dwan K, Kirkham J, Paton RW, Morley E, Newton AW, Perry DC. Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age. Cochrane Database Syst Rev. 2022 Oct 10;10(10):CD012717. doi: 10.1002/14651858.CD012717.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BBH (RB 16-057)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.